Beth Faiman, PhD, APRN-BC, AOCN
Editor in Chief

Beth Faiman elaborates on her idea wish list of resources and tools that would help her to better manage patients on oral oncolytics.

I often think of what my wish list would be for in a perfect world, how I would manage patients on in all oral regimen. If I could have somebody that could create calendars for may patients.

We have lots of tools that auto‑populate. But with these complex regimens, it's a challenge to get the dates right. If they miss a dose, how does that address? If I could have somebody to create a calendar or tool to help manage, that would be great.

The pharmaceutical companies and the pharmacies have staff, as I mentioned before, that help remind me to refill. Because remember these drugs are dosed, most of them at a monthly basis. At the end of each month, many of the drugs have to be refilled.

If there is a delay in dispensing on my end and a delay in dispensing on the pharmacy end, then that could put the patients off schedule. Keeping those resources available, those reminders available help me to do my job and help the patient get what they need.

Related Items
From The Editor - TON March 2018
Beth Faiman, PhD, APRN-BC, AOCN
TON - March 2018, Vol 11, No 1 published on March 9, 2018 in From the Editors
Emerging Safety Data with Checkpoint Inhibitors
Phoebe Starr
TON - November 2017, Vol 10, No 6 published on November 27, 2017 in Conference Correspondent
Psychological Distress in Patients with Cancer Warrants Attention
Phoebe Starr
TON - November 2017, Vol 10, No 6 published on November 27, 2017 in Conference Correspondent
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - November 2017, Vol 10, No 6 published on November 27, 2017 in From the Editors
Patients’ Chemotherapy-Related Side-Effect Concerns Have Evolved, But Hair Loss Remains Significant
Phoebe Starr
TON - November 2017, Vol 10, No 6 published on November 27, 2017 in Conference Correspondent
Increased Cancer Risk in Postmenopausal Women with Central Obesity
Phoebe Starr
TON - November 2017, Vol 10, No 6 published on November 27, 2017 in Conference Correspondent
Patients’ Fears of Radiation Side Effects Largely Unfounded
Phoebe Starr
TON - November 2017, Vol 10, No 6 published on November 27, 2017 in Conference Correspondent
Netupitant plus Palonosetron Noninferior to Aprepitant plus Granisetron in Patients Receiving Highly Emetogenic Chemotherapy
Li Zhang, MD
TON - November 2017, Vol 10, No 6 published on November 27, 2017 in Conference Correspondent
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - September 2017, Vol 10, No 5 published on September 10, 2017 in Cancer Center Profile
Patient-Reported Outcomes Influence Radiation Guidelines
Alice Goodman
TON - September 2017, Vol 10, No 5 published on September 10, 2017 in Conference Correspondent
Last modified: December 5, 2017